Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Oral Drug Approved for Spinal Muscular Atrophy

Oral Drug Approved for Spinal Muscular Atrophy News & Analysis News From the Food and Drug Administration CBD Drug Is Approved for a Third Form health risks from chronic dietary exposure food production and plan to monitor PFAS of Epilepsy to the chemicals, FDA officials said. The levels in the food supply. A drug containing the marijuana derivative data pertain to short-chain PFAS that con- cannabidiol (CBD) was approved to treat sei- tain 6:2 fluorotelomer alcohol (6:2 FTOH), Oral Drug Approved for Spinal zures associated with tuberous sclerosis which the agency noted may migrate to Muscular Atrophy complex (TSC) in patients aged 1 year or food and cannot be removed by washing The first oral therapy for adults and chil- older.TSCisageneticdiseasethatcausesbe- or cooking. dren aged 2 months or older who have spinal muscular atrophy (SMA) has received nign tumors to grow throughout the body. It affects 1 in 6000 people. FDA approval. A fatal genetic disease that leads to The drug, marketed as Epidiolex, is the only FDA-approved drug with CBD as an severe muscle weakness, SMA affects about 1 in 8000 to 10 000 people world- active ingredient. It was approved in 2018 to treat seizures in patients with Dravet or wide. Infants with SMA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Oral Drug Approved for Spinal Muscular Atrophy

JAMA , Volume 324 (11) – Sep 15, 2020

Oral Drug Approved for Spinal Muscular Atrophy

Abstract

News & Analysis News From the Food and Drug Administration CBD Drug Is Approved for a Third Form health risks from chronic dietary exposure food production and plan to monitor PFAS of Epilepsy to the chemicals, FDA officials said. The levels in the food supply. A drug containing the marijuana derivative data pertain to short-chain PFAS that con- cannabidiol (CBD) was approved to treat sei- tain 6:2 fluorotelomer alcohol (6:2 FTOH), Oral Drug Approved for Spinal zures associated with...
Loading next page...
 
/lp/american-medical-association/oral-drug-approved-for-spinal-muscular-atrophy-sFOfq0bg8R
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.16783
Publisher site
See Article on Publisher Site

Abstract

News & Analysis News From the Food and Drug Administration CBD Drug Is Approved for a Third Form health risks from chronic dietary exposure food production and plan to monitor PFAS of Epilepsy to the chemicals, FDA officials said. The levels in the food supply. A drug containing the marijuana derivative data pertain to short-chain PFAS that con- cannabidiol (CBD) was approved to treat sei- tain 6:2 fluorotelomer alcohol (6:2 FTOH), Oral Drug Approved for Spinal zures associated with tuberous sclerosis which the agency noted may migrate to Muscular Atrophy complex (TSC) in patients aged 1 year or food and cannot be removed by washing The first oral therapy for adults and chil- older.TSCisageneticdiseasethatcausesbe- or cooking. dren aged 2 months or older who have spinal muscular atrophy (SMA) has received nign tumors to grow throughout the body. It affects 1 in 6000 people. FDA approval. A fatal genetic disease that leads to The drug, marketed as Epidiolex, is the only FDA-approved drug with CBD as an severe muscle weakness, SMA affects about 1 in 8000 to 10 000 people world- active ingredient. It was approved in 2018 to treat seizures in patients with Dravet or wide. Infants with SMA

Journal

JAMAAmerican Medical Association

Published: Sep 15, 2020

There are no references for this article.